NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes

Diabetes Care

Volumn 30, Issue 3, 2007, Pages 689-693

  Zineh, Issam ^a   Beitelshees, Amber L ^b   Haller, Michael J ^c,d  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d Pediatric Endocrinology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; ATORVASTATIN; GLUTAMIC ACID; PLACEBO;

ADOLESCENT; AGE DISTRIBUTION; ARTERY DISEASE; ARTERY STIFFNESS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DOUBLE BLIND PROCEDURE; FEMALE; GENE; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NOS3 GENE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEX DIFFERENCE; TONOMETRY;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTERIAL OCCLUSIVE DISEASES; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; GENE FREQUENCY; HUMANS; MULTIVARIATE ANALYSIS; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33847622595     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1697     Document Type: Article

References (28)

1. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ: The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications study experience. Diabetes 55:1463-1469, 2006
2. Jarvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, Lehtimaki T, Ronnemaa T, Viikari J, Raitakari OT: Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 109:1750-1755, 2004
3. Singh TP, Groehn H, Kazmers A: Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol 41:661-665, 2003
4. Schalkwijk CG, Stehouwer CD: Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 109:143-159, 2005
5. Haller MJ, Samyn M, Nichols WW, Brusko T, Wasserfall C, Schwartz RF, Atkinson M, Shuster JJ, Pierce GL, Silverstein JH: Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. Diabetes Care 27:2911-2917, 2004
6. Farkas K, Jermendy G, Herold M, Ruzicska E, Sasvari M, Somogyi A: Impairment of the NO/cGMP pathway in the fasting and postprandial state in type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes 112:258-263, 2004
7. Bolego C, Buccellati C, Radaelli T, Cetin I, Puglisi L, Folco G, Sala A: eNOS, COX-2, and prostacyclin production are impaired in endothelial cells from diabetics. Biochem Biophys Res Commun 339:188-190, 2006
8. Haller MJ, Pierce GL, Braith RW, Silverstein JH: Serum superoxide dismutase activity and nitric oxide do not correlate with arterial stiffness in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 19:267-269, 2006
9. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K: T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864-2870, 1999
10. Rossi GP, Cesari M, Zanchetta M, Colonna S, Maiolino G, Pedon L, Cavallin M, Maiolino P, Pessina AC: The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 41:930-937, 2003
11. 298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100:1515-1520, 1999
12. 298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 32:735-740, 2001
13. 298Asp polymorphism with end-stage renal disease. Hypertension 40:535-540, 2002
14. 298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 20:2023-2027, 2002
15. Taverna MJ, Elgrably F, Selmi H, Selam JL, Slama G: The T-786C and C774T endothelial nitric oxide synthase gene polymorphisms independently affect the onset pattern of severe diabetic retinopathy. Nitric Oxide 13:88-92, 2005
16. Awata T, Neda T, Iizuka H, Kurihara S, Ohkubo T, Takata N, Osaki M, Watanabe M, Nakashima Y, Sawa T, Inukai K, Inoue I, Shibuya M, Mori K, Yoneya S, Katayama S: Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes. Diabetes Care 27:2184-2190, 2004
17. Taverna MJ, Sola A, Guyot-Argenton C, Pacher N, Bruzzo F, Chevalier A, Slama G, Reach G, Selam JL: eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy. Diabet Med 19:240 -245, 2002
18. Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS: Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 57:405-413, 2000
19. Liu Y, Burdon KP, Langefeld CD, Beck SR, Wagenknecht LE, Rich SS, Bowden DW, Freedman BI: T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study. J Am Soc Nephrol 16:1085-1090, 2005
20. Ohtoshi K, Yamasaki Y, Gorogawa S, Hayaishi-Okano R, Node K, Matsuhisa M, Kajimoto Y, Hori M: Association of (-)786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance. Diabetologia 45:1594-1601, 2002
21. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, Kass DA: Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation 95:1827-1836, 1997
22. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP: An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 14:160 -167, 1993
23. Pauca AL, O'Rourke MF, Kon ND: Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 38:932-937, 2001
24. Lemogoum D, Flores G, Van den Abeele W, Ciarka A, Leeman M, Degaute JP, van de Borne P, Van Bortel L: Validity of pulse pressure and augmentation index as surrogate measures of arterial stiffness during beta-adrenergic stimulation. J Hypertens 22:511-517, 2004
25. O'Rourke MF, Nichols WW, O'Brien E: Effects of ramipril on arterial stiffness. Hypertension 46:e14, 2005
26. Nichols WW, O'Rourke MF: Carotid artery augmentation index as a marker of cardiovascular risk. J Hypertens 21:1773-1774, 2003
27. O'Rourke MF, Nichols WW, Safar ME: Pulse waveform analysis and arterial stiffness: realism can replace evangelism and scepticism. J Hypertens 22:1633-1634, 2004
28. Hope SA, Tay DB, Meredith IT, Cameron JD: Use of arterial transfer functions for the derivation of central aortic waveform characteristics in subjects with type 2 diabetes and cardiovascular disease. Diabetes Care 27:746-751, 2004